Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes (Q24170228)

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

7 January 2021

Diabetic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Diabetic cardiomyopathy: fact or fiction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Oxidative stress and diabetic cardiomyopathy: a brief review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Xenobiotic-activated receptors: from transcription to drug metabolism to disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Nrf2 is essential for protection against acute pulmonary injury in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap n collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2·Keap1·Cul3 complex and recruiting Nrf2·Maf to the antioxidant response element enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Regulatory mechanisms controlling gene expression mediated by the antioxidant response element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Protection against Chromium (VI)-induced oxidative stress and apoptosis by Nrf2. Recruiting Nrf2 into the nucleus and disrupting the nuclear Nrf2/Keap1 association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Activation of Nrf2 in defense against cadmium-induced oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Nuclear factor E2-related factor 2-dependent myocardiac cytoprotection against oxidative and electrophilic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

iPLA2 inhibitor blocks negative inotropic effect of HIV gp120 on cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Superinduction of CYP1A1 gene expression. Regulation of 2,3,7,8- tetrachlorodibenzo-p-dioxin-induced degradation of Ah receptor by cycloheximide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Diabetes and the impairment of reproductive function: possible role of mitochondria and reactive oxygen species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Impact of mitochondrial ROS production in the pathogenesis of insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Impact of mitochondrial ROS production on diabetic vascular complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Diabetic Cardiomyopathy in OVE26 Mice Shows Mitochondrial ROS Production and Divergence Between In Vivo and In Vitro Contractility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Reactive oxygen species have a causal role in multiple forms of insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Replicating Huntington's disease phenotype in experimental animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Biochemistry and molecular cell biology of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Understanding RAGE, the receptor for advanced glycation end products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

3-nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Oxidative stress and mitochondrial dysfunction in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.007